- Home
- USA vs HRMY Comparison
USA vs HRMY Comparison
Compare USA & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USA
- HRMY
- Stock Information
- Founded
- USA 1986
- HRMY 2017
- Country
- USA United States
- HRMY United States
- Employees
- USA N/A
- HRMY N/A
- Industry
- USA Finance Companies
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- USA Finance
- HRMY Health Care
- Exchange
- USA Nasdaq
- HRMY Nasdaq
- Market Cap
- USA 2.0B
- HRMY 1.9B
- IPO Year
- USA N/A
- HRMY 2020
- Fundamental
- Price
- USA $6.99
- HRMY $34.83
- Analyst Decision
- USA
- HRMY Buy
- Analyst Count
- USA 0
- HRMY 10
- Target Price
- USA N/A
- HRMY $49.80
- AVG Volume (30 Days)
- USA 880.5K
- HRMY 539.5K
- Earning Date
- USA 01-01-0001
- HRMY 02-20-2025
- Dividend Yield
- USA 9.66%
- HRMY N/A
- EPS Growth
- USA N/A
- HRMY N/A
- EPS
- USA N/A
- HRMY 2.11
- Revenue
- USA N/A
- HRMY $681,879,000.00
- Revenue This Year
- USA N/A
- HRMY $24.83
- Revenue Next Year
- USA N/A
- HRMY $18.66
- P/E Ratio
- USA N/A
- HRMY $16.53
- Revenue Growth
- USA N/A
- HRMY 25.83
- 52 Week Low
- USA $5.62
- HRMY $28.14
- 52 Week High
- USA $7.09
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- USA 41.84
- HRMY 55.30
- Support Level
- USA $6.90
- HRMY $33.36
- Resistance Level
- USA $7.06
- HRMY $34.96
- Average True Range (ATR)
- USA 0.11
- HRMY 1.19
- MACD
- USA -0.01
- HRMY 0.16
- Stochastic Oscillator
- USA 43.14
- HRMY 81.62
About USA Liberty All-Star Equity Fund
Liberty All Star Equity Fund is a closed-end funds and open-end multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing primarily in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication and other services.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.